Evidence map›Paper›PMID 32001435›Full record

ArticleCMAJ open

Incidence and economic burden of

Jennifer A Pereira, Allison McGeer, Antigona Tomovici, Alex Selmani, Ayman Chit

Abstract read
In one paragraph

Article in CMAJ open. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Economic Burden of Clostridioides difficile Infection in European Countries.Advances in experimental medicine and biology · 2024
    Article
  5. Incidence, healthcare and out-of-pocket costs, and mortality ofAntimicrobial stewardship & healthcare epidemiology : ASHE · 2024
    Article
  6. Article
  7. Healthcare Costs ofOpen forum infectious diseases · 2023
    Article
  8. Costs Attributable to Clostridioides difficile Infection Based on the Setting of Onset.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023
    Article
  9. Evidence of within-facility patient-patientEpidemiology and infection · 2022
    Article
  10. Adoption and Trends in Uptake of Updated ICD-10 Codes forOpen forum infectious diseases · 2022
    Article
  11. Article
  12. Fecal Microbiota Transplantation for Severe or FulminantJournal of the Canadian Association of Gastroenterology · 2022
    Article
  13. Article
  14. Article
  15. Epidemiology of community-acquired and recurrentTherapeutic advances in gastroenterology · 2021
    Review
  16. The Economic Burden ofFrontiers in public health · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jennifer A PereiraJRL Research and Consulting (Pereira), Mississauga, Ont.; Department of Microbiology (McGeer), Mount Sinai Hospital; Sanofi Pasteur (Tomovici), Toronto, Ont.; Sanofi Pasteur (Selmani, Chit), Swiftwater, Penn. jennifer.pereira@jrlresearch.com.
Allison McGeerJRL Research and Consulting (Pereira), Mississauga, Ont.; Department of Microbiology (McGeer), Mount Sinai Hospital; Sanofi Pasteur (Tomovici), Toronto, Ont.; Sanofi Pasteur (Selmani, Chit), Swiftwater, Penn.
Antigona TomoviciJRL Research and Consulting (Pereira), Mississauga, Ont.; Department of Microbiology (McGeer), Mount Sinai Hospital; Sanofi Pasteur (Tomovici), Toronto, Ont.; Sanofi Pasteur (Selmani, Chit), Swiftwater, Penn.
Alex SelmaniJRL Research and Consulting (Pereira), Mississauga, Ont.; Department of Microbiology (McGeer), Mount Sinai Hospital; Sanofi Pasteur (Tomovici), Toronto, Ont.; Sanofi Pasteur (Selmani, Chit), Swiftwater, Penn.
Ayman ChitJRL Research and Consulting (Pereira), Mississauga, Ont.; Department of Microbiology (McGeer), Mount Sinai Hospital; Sanofi Pasteur (Tomovici), Toronto, Ont.; Sanofi Pasteur (Selmani, Chit), Swiftwater, Penn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUnderstanding the impact of prevention programs on

methodsWe performed a retrospective analysis using individual-level data from Ontario health databases from Apr. 1, 2005, to Mar. 31, 2015, identifying rates of

resultsOver the study period, 33 909 people in Ontario were admitted to hospital with

interpretationCommunity-associated

Indexed as

Clostridioides difficileCost of IllnessAdolescentAdultAgedAged, 80 and overClostridium InfectionsCohort StudiesCross InfectionFemaleHumansIncidenceMaleMiddle AgedOntarioPopulation Surveillance

Identifiers

PMID32001435
PMCPMC7004222

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.